Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Mar;74(3):1718-24.
doi: 10.1128/IAI.74.3.1718-1724.2006.

Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB/c model of progressive pulmonary tuberculosis

Affiliations

Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB/c model of progressive pulmonary tuberculosis

Antonia Isabel Castillo-Rodal et al. Infect Immun. 2006 Mar.

Abstract

Mycobacterium bovis BCG is the only available vaccine against tuberculosis. Reasons for why diverse BCG substrains induce different levels of protection in clinical trials remain unclear. The aim of this study was to compare the effectiveness of 10 BCG substrains in a mouse model of pulmonary tuberculosis. BALB/c mice were subcutaneously vaccinated and 2 months later were challenged with Mycobacterium tuberculosis H37Rv by intratracheal injection. Two and 4 months after challenge, delayed-type hypersensitivity (DTH) response, lung tissue affected by pneumonia, CFU, T-cell counts, and cytokine expression (interleukin-2 [IL-2], IL-4, IL-10, and gamma interferon) were determined. A differential protective effect of the diverse BCG substrains was found. BCG Phipps led to the largest and most persistent reduction of CFU counts and of the area of pneumonia at 2 and 4 months after challenge. This protection was accompanied by reduced IL-10-producing T cells. Contemporary BCG substrains induce a wide range of protection in this animal model. These data can help in the selection of the best vaccine for human immunization and for the development of novel recombinant BCG-based vaccine.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
CD4+, CD8+ lymphocyte subset found in the lungs of mice immunized with 10 different BCG daughter strains 4 months after infection with Mycobacterium tuberculosis H37Rv. Analysis was performed on suspensions of pooled cells from four mice per group. Each bar represents the percentage of CD4+ and CD8+ T cells.
FIG. 2.
FIG. 2.
Local immune response in the lungs of mice immunized using BCG substrains and infected with Mycobacterium tuberculosis H37Rv. Nonvaccinated (control) and BCG-vaccinated groups were sacrificed 4 months after infection. Analysis was performed on suspensions of pooled cells from four mice per group. Data represent the percentage of cytokine-producing cells.

Similar articles

Cited by

References

    1. Abolhassani, M., M. Lagranderie, P. Chavarot, A. M. Balazuc, and G. Marchal. 2000. Mycobacterium bovis BCG induces similar immune responses and protection by rectal and parenteral immunization routes. Infect. Immun. 68:5657-5662. - PMC - PubMed
    1. Abou-Zeid, C., I. Smith, J. Grange, J. Steele, and G. Rook. 1986. Subdivision of daughter strains of bacille Calmette-Guerin (BCG) according to secreted protein patterns. J. Gen. Microbiol. 132:3047-3053. - PubMed
    1. Anonymous.1978. Phenotypes of BCG-vaccines seed lot strains: results of an international cooperative study. International Union against Tuberculosis. Tubercle 59:139-142. - PubMed
    1. Anonymous.2003. WHO annual report on global TB control-summary. Wkly. Epidemiol. Rec. 78:122-128. - PubMed
    1. Behr, M. A. 2001. Correlation between BCG genomics and protective efficacy. Scand. J. Infect. Dis. 33:249-252. - PubMed

Publication types

MeSH terms

LinkOut - more resources